Leonteq Securities AG
CORT icon

Leonteq Securities AG’s Corcept Therapeutics CORT Stock Holding History

Leonteq Securities AG’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40.3K Sell
350
-25
-7% -$2.69K ﹤0.01% 819
2026
Q2 		$32.6K Buy
+375
New +$22.6K ﹤0.01% 888
2025
Q3 		– Sell
-90
Closed -$6.61K – 1333
2025
Q2 		$6.61K Buy
+90
New +$6.52K ﹤0.01% 1108
2024
Q4 		– Sell
-200
Closed -$9.26K – 1279
2024
Q3 		$9.26K Buy
+200
New +$7.11K ﹤0.01% 987
2021
Q3 		– Sell
-1,100
Closed -$24.2K – 1145
2021
Q2 		$24.2K Buy
+1,100
New +$24.5K ﹤0.01% 924

Other funds holding CORT

Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Emerald Advisers
Emerald Advisers Leola, Pennsylvania $3.64B AUM 71.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Emerald Mutual Fund Advisers Trust
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.45B AUM 70.46% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Boston Trust Walden
Boston Trust Walden Boston, Massachusetts $12.4B AUM 21.62% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Leonteq Securities AG's CORT Position: Q3 2026 in Review

Leonteq Securities AG reduced its Corcept Therapeutics (CORT) stake by 6.7% in Q3 2026, selling an estimated $2.69K and leaving 350 shares worth $40.3K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

Leonteq Securities AG first reported a position in CORT in Q2 2021 and has held it in 5 quarters since. 242 funds tracked by Wall St. Rank hold CORT as of Q3 2026.

  • Leonteq Securities AG held 350 shares of Corcept Therapeutics worth $40.3K as of Q3 2026.
  • Leonteq Securities AG sold 25 Corcept Therapeutics shares in Q3 2026, an estimated $2.69K.
  • Corcept Therapeutics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q3 2026, its #819 holding.
  • Leonteq Securities AG first reported a position in Corcept Therapeutics in Q2 2021 and has held it in 5 quarters since.
  • 242 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.

Based on Leonteq Securities AG's 13F filing for Q3 2026, filed 29 Oct 2026.